"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 ...

Monday’s trillion-dollar stock-market wipeout will be remembered as an opportunity to scoop up shares of some of the most ...

Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...

Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...

In this article, we will take a look into The Goldman Sachs Group Inc's (NYSE:GS) DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash ...

Goldman Sachs stock is not overvalued as growth in revenue and EPS is impressive. Click here to find out why I believe GS is ...

Goldman Sachs Group Inc (GS) stock saw a modest uptick, ending the day at $637.8 which represents a slight increase of $4.52 or 0.71% from the prior close of $633.28. The stock opened at $632.2 and ...

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...